Pay in 4 interest-free payments of $5.88 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Exenatides early success set important precedents
Clinical trials have shown that sitagliptin reduces hemoglobin A1c (a measure of average blood sugar over three months) by approximately 0.5 to 1.5 percentage points when used alone or in combination with other diabetes medications
(A placebo is a treatment that doesnt contain any active drug.) For details on these studies, see the Synjardy for diabetes section below
Frequently asked questions What is ColonBroom, and how does it work
US$ 23.16
US$ 21.75
US$ 22.24
US$ 28.65
US$ 21.86
